What is iStent?
For patients with both glaucoma and cataracts, iStent Trabecular Micro-Bypass stent is a new, FDA-approved surgical therapy that can significantly reduce eye pressure to help prevent vision loss. The iStent is placed in the eye during cataract surgery for the reduction of intraocular pressure (IOP) in adult patients with mild to moderate open-angle glaucoma.
How does iStent work?
The iStent is the first device that improves the eye’s natural fluid outflow to safely lower eye pressure by creating a permanent opening in the trabecular meshwork. Controlling eye pressure is extremely important to reduce the risk for vision loss due to glaucoma. The primary cause of elevated intraocular pressure (IOP) in patients with open-angle glaucoma is a blockage of the trabecular meshwork. iStent is designed to create a permanent opening in your eye’s drainage system to improve the outflow of fluid from your eyes. By increasing fluid outflow, iStent lowers pressure within the eye.
How can iStent help me?
The iStent is the smallest medical device ever approved by the FDA. It is so small, you won’t be able to see or feel it after surgery but it will be continuously working to help reduce eye pressure.
Proven safe and effective, the iStent Trabecular Micro-Bypass:
• Is safely implanted during cataract surgery
• Spares important eye tissue that could be damaged by traditional surgeries
• Does not limit treatment options that could help maintain your vision in the future
iStent is covered by Medicare and many private insurance plans. If you are going to have cataract surgery and are currently taking one or more medications to lower your eye pressure, you may be a candidate for iStent.